πŸ‡ΊπŸ‡Έ FDA
Patent

US 7335499

tRNA synthetase

granted A61KA61K2039/51A61K38/00

Quick answer

US patent 7335499 (tRNA synthetase) held by Replidyne, Inc. expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Replidyne, Inc.
Grant date
Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K2039/51, A61K38/00, A61K39/00, A61K48/00